Document Detail


Calcium supplementation and prevention of pregnancy induced hypertension.
MedLine Citation:
PMID:  8987323     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a randomized controlled trial 201 healthy nulliparous women were randomly allocated by means of a computer generated randomization list. From 20 weeks of gestation until delivery they received either 2 g of oral elemental calcium (n = 103) per day or an identical placebo (n = 98). Eleven women (5.47%) were lost to follow-up after randomization. The study groups were very similar at the time of randomization; with respect to several clinical and demographic variables. Treatment compliance was very similar in both groups as was determined by pill count. The rate of pregnancy induced hypertension was lower in the calcium group than in the placebo group 8.24%; vs 29.03%; (RR = 0.28; 95% CI 0.14-0.59). The incidence of gestational hypertension was 6.18% in the calcium group and 17.20% in the placebo group (RR = 0.28; 95% CI 0.08-0.80), and the incidence of preeclampsia was 2.06% in the calcium group and 11.82% in the placebo group (RR = 0.13; 95% CI 0.01-0.64). In conclusion calcium supplementation given in pregnancy to nulliparous women reduces the incidence of pregnancy induced hypertension.
Authors:
M Purwar; H Kulkarni; V Motghare; S Dhole
Related Documents :
12015513 - Risk of adverse pregnancy outcomes in young adolescent parturients in an inner-city hos...
18538263 - Increased risks of neonatal and postneonatal mortality associated with teenage pregnanc...
8373123 - Management of fetal sacroccocygeal teratoma.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The journal of obstetrics and gynaecology research     Volume:  22     ISSN:  1341-8076     ISO Abbreviation:  J. Obstet. Gynaecol. Res.     Publication Date:  1996 Oct 
Date Detail:
Created Date:  1997-03-19     Completed Date:  1997-03-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9612761     Medline TA:  J Obstet Gynaecol Res     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  425-30     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Government Medical College, Nagpur, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Calcium / administration & dosage,  therapeutic use*
Double-Blind Method
Female
Humans
Hypertension / prevention & control*
Placebos
Pre-Eclampsia / prevention & control
Pregnancy
Pregnancy Complications, Cardiovascular / prevention & control*
Pregnancy Outcome
Prospective Studies
Chemical
Reg. No./Substance:
0/Placebos; 7440-70-2/Calcium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary embolism associated with Sjögren's syndrome in pregnancy.
Next Document:  Outcome of unplanned vaginal deliveries after two previous caesarean sections.